List view / Grid view

Sandra Horning

 

news

Roche presents data for hemophilia A therapy ACE910

Roche presented data from a first-in-patient study of the novel…

9 December 2014 | By Roche

Roche presented data from a first-in-patient study of the novel humanised bispecific antibody ACE910 (RG6013) in hemophilia A patients during the 56th American Society of Hematology (ASH) Annual Meeting...

news

FDA grants Priority Review for Lucentis in diabetic retinopathy

Roche announced that the U.S. Food and Drug Administration has…

9 October 2014 | By Roche

Roche announced that the U.S. Food and Drug Administration has accepted to file the company's supplemental Biologics License Application and granted Priority Review of Lucentis (ranibizumab injection) for the treatment of diabetic retinopathy, an eye disease that impacts nearly 7.7 million Americans...

news

Roche to present latest oncology advances during ESMO 2014 Congress

Roche announced that important new data from its established and…

17 September 2014 | By Roche

Roche announced that important new data from its established and pipeline medicine portfolio will be presented during the European Society for Medical Oncology (ESMO) 2014 Congress from 26-30 September in Madrid, Spain...

news

FDA grants Roche’s Avastin Priority Review for certain types of cervical cancer

Roche announced that the U.S. Food and Drug Administration has…

15 July 2014 | By Roche

Roche announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application and granted Priority Review for Avastin (bevacizumab) plus chemotherapy for the treatment of women with persistent, recurrent or metastatic cervical cancer...